Resources

13
Mar

WEBINAR #7 Naked Immunology – Mast Cells – Marcus Maurer

Top-level science through the eyes of an expert.The seventh Webinar. This webinar episode is open to English-speaking participants with a solid scientific background. Featured speaker is Dr. Marcus Maurer, MD, Professor of Dermatology and Allergy, Co‐Director for the Fraunhofer Site for Immunology and Allergology of the Fraunhofer Translational Medicine and Pharmacology ITMP and Executive Director for the Institute of Allergology,
Read more
29
Feb

The silent crisis in biomedical research: beyond macaques

The Silent Crisis in Biomedical Research: Beyond MacaquesFinding an alternative to non-human primates to evaluate human therapeutics In a compelling narrative echoed by Le Monde, the biomedical sector faces a silent crisis, highlighting the geopolitical intricacies and ethical quandaries of scientific research. At its core, the dwindling supply of non-human primates (NHPs), particularly macaques, essential for testing medical treatments, has
Read more
29
Feb

Immunogenicity series: Wanted immunogenicity for vaccine development

Immunogenicity SeriesPart 2 - Wanted Immunogenicity for Vaccine DevelopmentImmunogenicity is a key concept in vaccine development,referring to the ability of a vaccine to stimulate an immune response in the recipient. It is a desirable and critical characteristic because the effectiveness of a vaccine is directly linked to its ability to induce a robust and protective immune response. Vaccine Development: Global
Read more
9
Feb

Understanding local tolerance

Understanding Local Tolerance in drug developmentIn the ever-evolving field of drug development, ensuring the safety and efficacy of new therapeutic agents is paramount. A crucial aspect of this safety evaluation is the assessment of cytotoxicity – the potential of substances to harm or destroy cells. Particularly in the realm of skin cytotoxicity, the concept of Local Tolerance, especially in the
Read more
10
Jan

Immunogenicity series: Defining immunogenicity

Immunogenicity SeriesPart 1 - Defining immunogenicity Immunogenicity plays a pivotal role in drug and vaccine development and is essential for optimizing therapeutic efficacy and safetyby understanding the immune system's response to the compounds being tested. This is particularly crucial in the era of biologics and personalized medicine, where the fine balance between therapeutic benefit and immune reactivity is critical. Whether
Read more
31
Oct

The role of animal-free non-clinical platforms in drug development – Part 2

Redefining Local Toxicity AssessmentPart 2 - The Role of Animal-Free Non-Clinical Platforms in Drug Development. In the realm of non-clinical animal-free platforms, a transformative shift is unfolding in response to the challenges posed by drug-induced adverse reactionsa predominant factor leading to the discontinuation of drug development projects and the withdrawal of drugs from the market1. The imperative for accurate, ethical,
Read more